Nonsteroidal Anti-Inflammatory Drugs

Vaccine in vial, glass bottle

Pain

Non-Opioid IV Therapy Available for Managing Moderate to Severe Pain

By

Brian Park, PharmD

April 14, 2020

The treatment is approved for the management of moderate to severe pain, alone or in combination with non-nonsteroidal anti-inflammatory drugs in adult patients.

Practice Management

FDA Issues Statement Regarding NSAID Use and COVID-19

By

Diana Ernst, RPh

March 23, 2020

The Food and Drug Administration has issued a statement regarding the use of nonsteroidal anti-inflammatory drugs in patients with coronavirus disease 2019.

Practice Management

Patients May Be Taking Over the Counter Medications That Interaect Wtih Apixiban

November 14, 2019

Many patients take over-the-counter (OTC) products with potentially serious interactions with the direct-acting oral anticoagulant apixaban.

Vascular Neurology

Antidepressant, NSAID Use Raises Risk of Intracranial Hemorrhage

July 16, 2015

There was no indication that any particular type of antidepressant was associated with a greater risk.

Stroke

Stroke Mortality High in New First-Gen Cox-2 Inhibitor Users

November 6, 2014

Older nonsteroidal anti-inflammatory drugs that selectively inhibit cyclooxygenase-2 enzyme, like etodolac and diclofenac, upped stroke mortality.

Next post in Stroke

Risk for ‘Silent Stroke’ Doubles with Atrial Fibrillation